Document › Details

Allergy Therapeutics plc. (9/28/17). "Press Release: Preliminary Results".

	Organisation	Allergy Therapeutics plc (AIM: AGY)
	Group	Allergy Therapeutics (Group)
	Organisation 2	Allergy Therapeutics Iberia S.L.
	Group	Allergy Therapeutics (Group)
	Product	antiallergic
	Product 2	vaccine
	Person	Llobet, Manuel (Allergy Therapeutics 201709 CEO)
	Person 2	Wykeman, Nick (Allergy Therapeutics 201709 Finance Director)

Original document
accessed by [iito] on 2017-09-28

Record changed: 2017-10-08

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top

Top News

Upcoming Events

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Partners

Allergy Therapeutics plc. (9/28/17). "Press Release: Preliminary Results".